Ticker Symbol: HUAKF

Huakang Biomedical Holdings Company Limited

Exchange: US OTC Currency: USD Asset Type: Common Stock

Company Profile

Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The firm engages in the manufacture and sale of in-vitro diagnostic (IVD) reagents in China. Its product portfolio of IVD reagents consists of male fertility IVD reagents, parasite antibody detection reagents and an EBV antibody detection reagent. The company was founded on August 3, 2017 and is headquartered in Hong Kong.

Sector: Health Technology

Industry: Medical Specialties

Standard Industrial Classification Code (SIC code): 2835

Address: N/A

Website: N/A

CEO: Chun Guang Zhang

Tags:

Health Technology
Medical Specialties

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: - - -

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 400000000

Valuation

Market Cap: -

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A